In the near future, the 2021-2022 flu vaccination campaign poses several organizational problems since it would seem natural to think that an anti-Covid19 vaccination campaign of boosters with possible add-up of new strains, must have absolute priority. This is combined with the fact that there are serious doubts about the strain, or strains, against which to target influenza vaccination due to the extremely low circulation of the flu virus in general.